Literature DB >> 21270230

Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Doris Hillemann1, Sabine Rüsch-Gerdes, Catharina Boehme, Elvira Richter.   

Abstract

In total, 521 nonrespiratory specimens (91 urine, 30 gastric aspirate, 245 tissue, 113 pleural fluid, 19 cerebrospinal fluid [CSF], and 23 stool specimens) submitted to the German National Reference Laboratory for Mycobacteria (NRL) from May 2009 to August 2010 were comparatively investigated with the new molecular-based GeneXpert MTB/RIF (Xpert) assay system and conventional liquid and solid culture methods. Twenty (3.8%) of the 521 specimens gave no interpretable result. Whereas the sensitivity of the Xpert assay with tissue specimens was 69.0% (20 out of 29 culture-positive cases detected), 100% sensitivity was found with the urine and stool specimens. The combined sensitivity and specificity of the Xpert assay were calculated to be 77.3% and 98.2%, respectively.

Entities:  

Mesh:

Year:  2011        PMID: 21270230      PMCID: PMC3122824          DOI: 10.1128/JCM.02268-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis.

Authors:  V C C Cheng; W C Yam; I F N Hung; P C Y Woo; S K P Lau; B S F Tang; K Y Yuen
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

2.  Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures.

Authors:  Elvira Richter; Sabine Rüsch-Gerdes; Doris Hillemann
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

3.  Global epidemiology of tuberculosis.

Authors:  Christopher Dye
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

4.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.

Authors:  H Taniguchi; H Aramaki; Y Nikaido; Y Mizuguchi; M Nakamura; T Koga; S Yoshida
Journal:  FEMS Microbiol Lett       Date:  1996-10-15       Impact factor: 2.742

6.  Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons.

Authors:  H H El-Hajj; S A Marras; S Tyagi; F R Kramer; D Alland
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing.

Authors:  Siva Raja; Jesus Ching; Liqiang Xi; Steven J Hughes; Ronald Chang; Wendy Wong; William McMillan; William E Gooding; Kenneth S McCarty; Melissa Chestney; James D Luketich; Tony E Godfrey
Journal:  Clin Chem       Date:  2005-03-03       Impact factor: 8.327

9.  Polymerase chain reaction of pleural biopsy is a rapid and sensitive method for the diagnosis of tuberculous pleural effusion.

Authors:  Nadia A Hasaneen; Maysaa E Zaki; Hala M Shalaby; Ahmad S El-Morsi
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

10.  [Value of PCR amplification from formalin-fixed paraffin-embedded tissues in the diagnosis of Mycobacterium tuberculosis infection].

Authors:  Véronique Hofman; Eric Selva; Luce Landraud; Dominique Sicard; Nicolas Vénissac; Laurent Castillo; Alain Kermarec; Jérôme Mouroux; Pierre Dellamonica; Paul Hofman
Journal:  Ann Pathol       Date:  2003-06       Impact factor: 0.407

View more
  144 in total

1.  Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence.

Authors:  Raquel Moure; Rogelio Martín; Fernando Alcaide
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  [Genitourinary tuberculosis in Germany: diagnosis and treatment].

Authors:  S Lenk
Journal:  Urologe A       Date:  2011-12       Impact factor: 0.639

3.  Perspectives on introduction and implementation of new point-of-care diagnostic tests.

Authors:  Kara M Palamountain; Jeff Baker; Elliot P Cowan; Shaffiq Essajee; Laura T Mazzola; Mutsumi Metzler; Marco Schito; Wendy S Stevens; Gloria J Young; Gonzalo J Domingo
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

4.  Xpert MTB/RIF assay for diagnosis of pleural tuberculosis.

Authors:  Sven O Friedrich; Florian von Groote-Bidlingmaier; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

5.  Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.

Authors:  L E Scott; N Gous; B E Cunningham; B D Kana; O Perovic; L Erasmus; G J Coetzee; H Koornhof; W Stevens
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 6.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

7.  A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Pamela Nabeta; Amy L Davidow; Viral Vadwai; Rasim Tahirli; Vanisha Munsamy; Mark Nicol; Martin Jones; David H Persing; Doris Hillemann; Sabine Ruesch-Gerdes; Felicity Leisegang; Carlos Zamudio; Camilla Rodrigues; Catharina C Boehme; Mark D Perkins; David Alland
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

Review 8.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

9.  Isolated Splenic Cold Abscesses in an Immunocompetent Individual.

Authors:  Deba Prasad Dhibar; Bharath A Chhabria; Nanili Gupta; Subhash Chander Varma
Journal:  Oman Med J       Date:  2018-07

10.  Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner.

Authors:  Yu-Min Wang; Michael Patrick Trinh; Yongzan Zheng; Kaizhu Guo; Luis A Jimenez; Wenwan Zhong
Journal:  Trends Analyt Chem       Date:  2019-07-05       Impact factor: 12.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.